With the changes in the AstraZeneca vaccine, newer coronavirus variants, and supply limitations, many people wonder if they can “mix and match” vaccines against COVID-19.

SIGHT: H10N3 Avian Flu: How is it transmitted to humans?

This means, for example, receiving the AstraZeneca vaccine as the first dose, followed by a second dose of a different vaccine, such as the one from Pfizer, and boosters with other vaccines later on.

Although there are many ongoing studies, data from mix-and-match trials in Spain and the UK have recently been published.

SIGHT: Question of the day: Could H10N3 bird flu trigger a new pandemic? [VIDEO]

These data are very promising and suggest that mixed schemes can provide higher antibody levels than two doses of a single vaccine.

How does this formula work and why might it be a good idea?

SIGHT: The COVID-19 vaccines already approved by the WHO (and how they work)

What is the benefit of mixing and matching?

If the covid-19 vaccination program can mix and match vaccines, it greatly increases your flexibility.

Several countries in Europe are advising giving young people who received AstraZeneca in the first dose, a second dose of another vaccine. (GETTY IMAGES)

Having a flexible immunization program allows us to be agile in the face of global supply limitations. If there is a shortage of a vaccine, instead of stopping the whole process to wait for the supply, you can continue with a different vaccine, regardless of the one that was given as the first dose.

If one vaccine is less effective than another against a certain variant, mixed programs could ensure that people who have already received a dose of a less effective vaccine can get a booster with a more effective vaccine against the variant.

Some countries are already using mixed vaccination schedules after changing the AstraZeneca vaccine recommendations due to the occurrence of thrombi as a very rare side effect.

Several countries in Europe are now advising younger people who were previously given this vaccine as the first dose to receive an alternative vaccine as the second dose, most commonly mRNA vaccines like Pfizer’s.

Spain, Germany, France, Sweden, Norway and Denmark They are among the countries that recommend mixed vaccination schedules for this reason.

It is safe?

In a UK study of vaccine combination published in the Lancet, 830 adults over the age of 50 were randomly assigned to receive either the Pfizer or AstraZeneca vaccine first, and then the other.

Mixing vaccines allows for a more flexible vaccination schedule.  (GETTY IMAGES)

Mixing vaccines allows for a more flexible vaccination schedule. (GETTY IMAGES)

People who received mixed doses were found to were more likely to develop symptoms of mild to moderate from the second dose of the vaccine, including chills, fatigue, fever, headache, joint pain, malaise, muscle pain, and injection site pain, compared to those who received vaccines from the same company.

However, these Reactions were short-lived and there were no other safety concerns. Researchers have now adapted this study to see if early and regular use of acetaminophen reduces the frequency of these reactions.

Another similar study (not peer-reviewed) carried out in Spain has revealed that most of the side effects were mild or moderate and of short duration (two to three days). They were similar to the side effects of receiving two doses of the same vaccine.

It is effective?

Spanish work has shown that people had a much higher antibody response two weeks after receiving the Pfizer booster, following an initial dose of AstraZeneca.

These antibodies were able to recognize and inactivate the coronavirus in laboratory tests.

There are currently several ongoing studies to evaluate the results of the vaccine combination.  (GETTY IMAGES)

There are currently several ongoing studies to evaluate the results of the vaccine combination. (GETTY IMAGES)

This response to the Pfizer booster appears to be stronger than the response after receiving two doses of the AstraZeneca vaccine, based on previous data from the trial. The immune response of receiving the Pfizer vaccine followed by the AstraZeneca vaccine is not yet known, but the UK will have the results soon.

There is no data yet on the effectiveness of mixed schemes to prevent COVID-19, but they are likely to work well. The immune response is similar, or even better, compared to studies using the same vaccine as the first and second doses. This indicates that they will be effective in preventing disease.

Could you speed up vaccination programs?

In Spain, those under 60 who received the first dose of AstraZeneca can choose whether to continue with the same product or receive the Pfizer vaccine. Although the Ministry of Health recommends a second dose of Pfizer, many have chosen to stick with AstraZeneca.

Recent real-world findings from the UK suggest that after two doses, both vaccines are equally effective against the variants circulating in the British Isles.

The recommendations on changing the vaccine in different countries are due to concerns about the appearance of thrombi after the first dose of AstraZeneca, as well as the change in the age ranges of the citizens who receive it and supply problems.

This has led to widespread uncertainty and has meant that young people in some European countries who had already received a first dose were excluded from receiving a second dose.

The results of these mixed studies support the possibility of vaccinating those who have received the first dose of AstraZeneca with a different booster, if the need arises.

Further research is underway to evaluate mix and match schedules with Moderna and Novavax vaccines.

Don’t delay in getting vaccinated

While in some countries cases are decreasing, many others are experiencing an increase. Among them are Taiwan and Singapur, which were previously hailed as excellent examples of how to manage covid-19.

These examples highlight the difficulty of sustained virus suppression in the absence of high vaccination coverage. This will be aggravated by the new, more transmissible variants.

Current cases in many regions of Europe, the United States, and Australia are caused by the variant B.1.617.1 (“india”). Both vaccines are effective against variant B.1.617.2, closely related to india (although slightly less than against B.1.1.7), and similar efficacy would be expected against B.1.617.1.

While we wait, it is essential that people do not delay their vaccination with the product that is offered to them. Vaccination is an essential part of the exit strategy from the pandemic.

The vaccination schedule is likely to change in the future, as boosters may be necessary. This is normal in immunization programs. We already do it every year with the flu vaccine. This should not be viewed as a policy failure, but rather as an evidence-based response to new information.

By Fiona Russell is a researcher, pediatrician and epidemiologist at the University of Melbourne in Australia. John Hart is a clinical investigator at the Murdoch Children’s Research Institute. This article was published on The Conversation and reproduced here under the Creative Commons license. Click here to read the original version.



  • H10N3 Avian Flu: How is it transmitted to humans?
  • The COVID-19 vaccines already approved by the WHO (and how they work)
  • Only one of the lineages of the variant of the coronavirus detected in India is “worrying”
  • What is known about the Wuhan laboratory in China that the United States investigates as a possible origin of the coronavirus
  • Canada approves mixing doses of AstraZeneca and Pfizer vaccines
  • WHO approves emergency use of Chinese coronavirus vaccine Sinovac
  • The “black fungus” and COVID-19: what you should know about this dangerous disease
  • Pfizer’s vaccine works against the Indian variant but its effectiveness is “slightly less”
  • What is known about the new hybrid variant of COVID-19 that is causing an increase in cases in Vietnam
  • New strategies in the use of vaccines, by Elmer Huerta

Follow us on twitter:

!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?’http’:’https’;if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+’://platform.twitter.com/widgets.js’;fjs.parentNode.insertBefore(js,fjs);}}(document, ‘script’, ‘twitter-wjs’);


Disclaimer: If you need to update/edit/remove this news or article then please contact our support team Learn more